CoChat

The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Abstract

Remyelination of primary demyelinated lesions is a common feature of experimental models of multiple sclerosis (MS) and is also suggested to be the normal response to demyelination during the early stages of MS itself. Many lines of evidence have shown that remyelination is preceded by the division of endogenous oligodendrocyte precursor cells (OPCs) in the lesion and its borders. It is suggested that this rapid response of OPCs to repopulate the lesion site and their subsequent differentiation into new oligodendrocytes is the key to the rapid remyelination. Antibodies to the NG2 chondroitin sulphate proteoglycan have proved exceedingly useful in following and quantitating the response of endogenous OPCs to demyelination. Here we review the literature on the response of NG2-expressing OPCs to demyelination and provide some new evidence on their response to the chronic inflammatory demyelinating environment seen in recombinant myelin oligodendrocyte glycoprotein (MOG) induced experimental allergic encephalomyelitis (EAE) in the DA rat. NG2-expressing OPCs responded to the inflammatory demyelination in this model by becoming reactive and increasing in number in a very focal manner. Evidence of NG2+ OPCs in lesioned areas beginning to express the oligodendrocyte marker CNP was also seen. The response of OPCs appeared to occur following successive relapses but did not always lead to remyelination, with areas of chronic demyelination observed in the spinal cord. The presence of OP…

Overview

Integrity signals

Registry

Crossref · 10.1023/a:1025747832215

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 57 references

Cited by

See all 177

Metadata

Authors
Reynolds, R., Dawson, M., Papadopoulos, D., Polito, A., di Bello, I. C., Pham-Dinh, D., & Levine, J.
Affiliations
  • Imperial College London (GB)
  • Inserm (FR)
  • Stony Brook University (US)
Venue
Journal of Neurocytology
Published
2002-07
Volume
31
Issue
6-7
Pages
523-536
ISSN
  • 0300-4864 (ISSN-L)
  • 1573-7381
OpenAlex
W1536744532
Cited by
175
References
49
Citations by year
2026: 2 · 2025: 3 · 2024: 1 · 2023: 2 · 2022: 3 · 2021: 3 · 2020: 7 · 2019: 6 · 2018: 7 · 2017: 6 · 2016: 6 · 2015: 7 · 2014: 7 · 2013: 15 · 2012: 12
FWCI
3.82
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Journal of Neurocytology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
Keywords
oligodendrocyte precursor cells, remyelination, demyelination, multiple sclerosis, experimental autoimmune encephalomyelitis, myelin oligodendrocyte glycoprotein, CNP, oligodendrocyte differentiation, relapse, chronic demyelination, spinal cord lesions, microglia
MeSH terms
Chondroitin Sulfate Proteoglycan 4, Animals, Antigens, Disease Models, Animal, Encephalomyelitis, Autoimmune, Experimental, Gliosis, Humans, Middle Aged, Multiple Sclerosis, Myelin Proteins, Myelin Sheath, Nerve Regeneration, Oligodendroglia, Proteoglycans, Recombinant Fusion Proteins, Stem Cells, Biomarkers, Myelin-Associated Glycoprotein, Cell Lineage, Rats, Myelin-Oligodendrocyte Glycoprotein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS. https://app.cochat.ai/papers/10.1023/a:1025747832215
The paper
Reynolds, R., Dawson, M., Papadopoulos, D., Polito, A., di Bello, I. C., Pham-Dinh, D., & Levine, J. (2002). The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS. Journal of Neurocytology. https://doi.org/10.1023/a%3A1025747832215

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.